日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium botulinum Thiamine-phosphate synthase (thiE) CSB-YP500321DUH
CSB-EP500321DUH
CSB-BP500321DUH
CSB-MP500321DUH
CSB-EP500321DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Hydroxyethylthiazole kinase 1 (thiM1) CSB-YP500322DUH
CSB-EP500322DUH
CSB-BP500322DUH
CSB-MP500322DUH
CSB-EP500322DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum D-alanine--D-alanine ligase (ddl) CSB-YP500323DUH
CSB-EP500323DUH
CSB-BP500323DUH
CSB-MP500323DUH
CSB-EP500323DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum tRNA (guanine-N (7)-)-methyltransferase CSB-YP500324DUH
CSB-EP500324DUH
CSB-BP500324DUH
CSB-MP500324DUH
CSB-EP500324DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Fructose-1,6-bisphosphatase class 3 (fbp), partial CSB-YP500325DUH
CSB-EP500325DUH
CSB-BP500325DUH
CSB-MP500325DUH
CSB-EP500325DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S2 (rpsB) CSB-YP500326DUH
CSB-EP500326DUH
CSB-BP500326DUH
CSB-MP500326DUH
CSB-EP500326DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum GTP-sensing transcriptional pleiotropic repressor CodY (codY) CSB-YP500327DUH
CSB-EP500327DUH
CSB-BP500327DUH
CSB-MP500327DUH
CSB-EP500327DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0102 protein CLM_2733 (CLM_2733) CSB-YP500328DUH
CSB-EP500328DUH
CSB-BP500328DUH
CSB-MP500328DUH
CSB-EP500328DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L19 (rplS) CSB-YP500329DUH
CSB-EP500329DUH
CSB-BP500329DUH
CSB-MP500329DUH
CSB-EP500329DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum tRNA (guanine-N (1)-)-methyltransferase CSB-YP500330DUH
CSB-EP500330DUH
CSB-BP500330DUH
CSB-MP500330DUH
CSB-EP500330DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S16 (rpsP) CSB-YP500331DUH
CSB-EP500331DUH
CSB-BP500331DUH
CSB-MP500331DUH
CSB-EP500331DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0122 protein CLM_2743 (CLM_2743) CSB-YP500332DUH
CSB-EP500332DUH
CSB-BP500332DUH
CSB-MP500332DUH
CSB-EP500332DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phosphate acyltransferase (plsX) CSB-YP500333DUH
CSB-EP500333DUH
CSB-BP500333DUH
CSB-MP500333DUH
CSB-EP500333DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Acetate kinase (ackA) CSB-YP500334DUH
CSB-EP500334DUH
CSB-BP500334DUH
CSB-MP500334DUH
CSB-EP500334DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0348 protein CLM_2790 (CLM_2790) CSB-YP500335DUH
CSB-EP500335DUH
CSB-BP500335DUH
CSB-MP500335DUH
CSB-EP500335DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Phosphopantetheine adenylyltransferase (coaD) CSB-YP500336DUH
CSB-EP500336DUH
CSB-BP500336DUH
CSB-MP500336DUH
CSB-EP500336DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L28 (rpmB) CSB-YP500337DUH
CSB-EP500337DUH
CSB-BP500337DUH
CSB-MP500337DUH
CSB-EP500337DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP500338DUH
CSB-EP500338DUH
CSB-BP500338DUH
CSB-MP500338DUH
CSB-EP500338DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP500339DUH
CSB-EP500339DUH
CSB-BP500339DUH
CSB-MP500339DUH
CSB-EP500339DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UPF0296 protein CLM_2815 (CLM_2815) CSB-YP500340DUH
CSB-EP500340DUH
CSB-BP500340DUH
CSB-MP500340DUH
CSB-EP500340DUH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×